212 related articles for article (PubMed ID: 15710119)
1. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
Nelson L; Bachoo P; Holmes J
Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
4. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
5. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
Heckmann M; Plewig G;
Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
8. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
Glogau RG
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
[TBL] [Abstract][Full Text] [Related]
9. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
[TBL] [Abstract][Full Text] [Related]
10. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
[TBL] [Abstract][Full Text] [Related]
13. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T; Konrad H; Karte K; Wollina U
Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
[No Abstract] [Full Text] [Related]
15. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
Maillard H; Briand N; Bara C; Celerier P
Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for axillary hyperhidrosis.
de Almeida AR; Montagner S
Dermatol Clin; 2014 Oct; 32(4):495-504. PubMed ID: 25152343
[TBL] [Abstract][Full Text] [Related]
17. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
[TBL] [Abstract][Full Text] [Related]
18. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
[TBL] [Abstract][Full Text] [Related]
20. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.
Wollina U; Köstler E; Schönlebe J; Haroske G
Dermatol Surg; 2008 May; 34(5):709-16. PubMed ID: 18318727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
